Strategic Roadmap
From Local Pilot to Global Youth-Led Change
Our Strategic Roadmap lays out a bold path to transform how Type 1 Diabetes (T1D) is detected, managed, and eventually cured. With youth leadership at its core, our strategy focuses on scaling innovation, education, and access from our Philadelphia base to national and global levels.
We are guided by three interconnected phases that build on each other, evolving from proof-of-concept to global transformation.
2025–2027
Launch patient-focused programs, innovation pilots, and key partnerships to deliver immediate impact.
2028–2030
Scale solutions to national and international levels, expand access, and intensify advocacy efforts.
2031–2035
Pioneer functional cures, establish global equity, and influence systemic change worldwide.
Our roadmap is not just a plan; it is a vision of hope and action that connects innovation with the lives of millions.
🩸 Phase 1: 2025–2027 – Youth-Powered Innovation & Access
Mission:Â Launch and validate programs that empower youth to lead in T1D research, care, and advocacy.
Key Goals:
- Serve 5,000+ patients with subsidized insulin, CGMs, and mental health support
- Train 500+ youth through our Leadership & Entrepreneurship Academy
- Launch youth-involved pilot projects in non-invasive glucose monitoring and beta-cell regeneration
- Host school-based screening and awareness events in 10 high-need communities
Featured Milestone:Â In 2026, our Healthy Futures Campaign identified 2,500+ undiagnosed prediabetes/T1D cases in Philadelphia.
Strategic Partners:
- Local clinics, schools, and hospitals
- University research labs and tech startups
- Youth councils and education nonprofits
🌍 Phase 2: 2028–2030 – Scaling Innovation & Youth Leadership
Mission:Â Expand proven programs to other cities and countries while elevating youth voices globally.
Key Goals:
- Support 50,000+ individuals globally with access to insulin and CGMs
- Launch regional Youth Innovation Hubs in North America, Latin America, and Africa
- Introduce the Kopp Innovation Fellowship for youth-led tech and advocacy solutions
- Build a global T1D school screening framework with cultural and language adaptability
Projected Outcome:Â 20% reduction in T1D-related hospitalizations in participating communities
Strategic Partners:
- Ministries of Health, global health NGOs, WHO affiliates
- Universities and accelerator programs
- Youth-led organizations and international school networks
🧬 Phase 3: 2031–2035 – Global Equity & Cure Acceleration
Mission:Â Support youth-led systemic change and bring cutting-edge therapies to every corner of the globe.
Key Goals:
- Fund and support clinical trials for regenerative therapies including gene editing and beta-cell restoration
- Integrate AI and non-invasive monitoring into standard care globally
- Host the first Global Youth T1D Summit to unite advocates, researchers, and policymakers
- Launch the Global Youth T1D Equity Index to track care disparities and drive action
Vision Statement: By 2035, we aim to make T1D a manageable and ultimately preventable condition for every young person—regardless of geography or income.
Strategic Partners:
- WHO, UNICEF, and international coalitions
- Leading biotech firms and T1D research centers
- Philanthropic investors and youth advocacy alliances
How to Join the Movement
Whether you’re a funder, educator, health system leader, or student advocate, your support fuels this transformation.
